Jersey Shore University Medical Center Announces Participation in C. difficile Vaccine Trial

August 1, 2013

Jersey Shore University Medical Center, <a href=order clostridium difficile infection, vaccine clinical trial” src=”” width=”269″ height=”105″ />The Jersey Shore University Medical Center in Neptune, New Jersey has announced it will be participating in a Phase III Trial of an investigational vaccine to prevent Clostridium difficile infections.

The clinical study will evaluate the “safety, immunogenicity and efficacy of an investigational vaccine for the prevention of primary symptomatic” Clostridium difficile infection (CDI).

Click here to read the Jersey Shore University News Release.

Leave a Comment

Previous post:

Next post: